Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Background Metformin in Patient With Type 2 Diabetes
Clinical trial NCT01778049 · COMPLETED
Trial details
- NCT number
- NCT01778049
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-01
- Primary completion
- 2015-03-01
- Enrollment
- 708
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.